$HZNP News Thursday’s biggest gaining and decl
Post# of 144521
Posted On: 03/13/2014 10:30:23 AM
$HZNP News
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma Discusses Q4 2013 Results (Webcast) 7:55 a.m. Today - Seeking Alpha
10-K: HORIZON PHARMA, INC. 7:04 a.m. Today - Edgar Online - (EDG = 10Q, 10K)
Will Horizon Pharma Spike Again On Quarterly Report? 7:02 a.m. March 12, 2014 - Investors Business Daily
New Lifetime High Today: Horizon Pharma (HZNP) 9:45 a.m. March 11, 2014 - TheStreet.com
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 6:30 a.m. March 6, 2014 - benzinga.com
Buy Horizon Pharma On Upcoming Revenue Growth 3:22 p.m. March 5, 2014 - Seeking Alpha
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 6:30 a.m. March 5, 2014 - benzinga.com
Biopharms That Won't Buy The Farm - Investment Ideas 3:37 p.m. Feb. 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Upgraded (HZNP) 10:11 a.m. Feb. 25, 2014 - TheStreet.com
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:36 a.m. Feb. 25, 2014 - Zacks.com
Should You Worry About the Short Interest in Horizon Pharma (HZNP)? - Tale of the Tape 10:13 a.m. Feb. 24, 2014 - Zacks.com
Horizon Pharma (HZNP) Shares March Higher, Can It Continue? - Tale of the Tape 9:14 a.m. Feb. 21, 2014 - Zacks.com
Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs 3:43 p.m. Feb. 11, 2014 - benzinga.com
Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2% - Tale of the Tape 9:25 a.m. Jan. 30, 2014 - Zacks.com
Why Horizon Pharma (HZNP) Is Up Today 2:44 p.m. Jan. 29, 2014 - TheStreet.com
New Lifetime High Reached By Horizon Pharma (HZNP) 10:35 a.m. Jan. 29, 2014 - TheStreet.com
5 Pharmaceutical Stocks to Buy Now 3:15 a.m. Jan. 24, 2014 - InvestorPlace.com
Affymetrix's Revenue Guidance Tops Ests - Analyst Blog 2:50 p.m. Jan. 8, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
A Classic Melt-Up 4:25 p.m. Dec. 20, 2013 - RealMoney.com
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. Today - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:50 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:30 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com
Horizon Pharma Discusses Q4 2013 Results (Webcast) 7:55 a.m. Today - Seeking Alpha
10-K: HORIZON PHARMA, INC. 7:04 a.m. Today - Edgar Online - (EDG = 10Q, 10K)
Will Horizon Pharma Spike Again On Quarterly Report? 7:02 a.m. March 12, 2014 - Investors Business Daily
New Lifetime High Today: Horizon Pharma (HZNP) 9:45 a.m. March 11, 2014 - TheStreet.com
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 6:30 a.m. March 6, 2014 - benzinga.com
Buy Horizon Pharma On Upcoming Revenue Growth 3:22 p.m. March 5, 2014 - Seeking Alpha
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 6:30 a.m. March 5, 2014 - benzinga.com
Biopharms That Won't Buy The Farm - Investment Ideas 3:37 p.m. Feb. 27, 2014 - Zacks.com
Horizon Pharma Inc Stock Upgraded (HZNP) 10:11 a.m. Feb. 25, 2014 - TheStreet.com
Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape 8:36 a.m. Feb. 25, 2014 - Zacks.com
Should You Worry About the Short Interest in Horizon Pharma (HZNP)? - Tale of the Tape 10:13 a.m. Feb. 24, 2014 - Zacks.com
Horizon Pharma (HZNP) Shares March Higher, Can It Continue? - Tale of the Tape 9:14 a.m. Feb. 21, 2014 - Zacks.com
Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs 3:43 p.m. Feb. 11, 2014 - benzinga.com
Horizon Pharma (HZNP) Catches Eye: Stock Soars 18.2% - Tale of the Tape 9:25 a.m. Jan. 30, 2014 - Zacks.com
Why Horizon Pharma (HZNP) Is Up Today 2:44 p.m. Jan. 29, 2014 - TheStreet.com
New Lifetime High Reached By Horizon Pharma (HZNP) 10:35 a.m. Jan. 29, 2014 - TheStreet.com
5 Pharmaceutical Stocks to Buy Now 3:15 a.m. Jan. 24, 2014 - InvestorPlace.com
Affymetrix's Revenue Guidance Tops Ests - Analyst Blog 2:50 p.m. Jan. 8, 2014 - Zacks.com
Patients Enrolled in Synageva Study - Analyst Blog 4:15 p.m. Jan. 7, 2014 - Zacks.com
A Classic Melt-Up 4:25 p.m. Dec. 20, 2013 - RealMoney.com
Horizon Pharma Reports 2013 Financial Results and Provides Business Update 6:30 a.m. Today - Marketwire
Egalet Appoints Timothy P. Walbert to Board of Directors 8:14 a.m. March 11, 2014 - GlobeNewswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7:30 a.m. March 6, 2014 - Marketwire
Horizon Pharma to Present at the 26th Annual ROTH Conference 7:30 a.m. March 6, 2014 - Marketwire
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 3:30 p.m. March 5, 2014 - PR Newswire - PRF
Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer 7:30 a.m. March 5, 2014 - Marketwire
Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13, 2014 7:44 a.m. Feb. 27, 2014 - Marketwire
Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference 7:30 a.m. Feb. 24, 2014 - Marketwire
Horizon Pharma Provides Update on February 10-11, 2014 FDA Joint Advisory Committee Meeting on Cardiovascular Risk of NSAIDs 4:40 p.m. Feb. 11, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:50 p.m. Feb. 6, 2014 - Marketwire
Biotech News for Advancing Pharma Stocks: Company's Test Results Surpass Expectations For $3.5 Billion ADHD Market 9:05 a.m. Feb. 4, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference 7:30 a.m. Feb. 4, 2014 - Marketwire
Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 15, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:05 p.m. Jan. 9, 2014 - Marketwire
Conference Presentation Schedules, Executive Appointments, and Product Availability - Research Report on Mallinckrodt, Haemonetics, Select Medical, Horizon Pharma, and ImmunoGen 8:00 a.m. Jan. 7, 2014 - PR Newswire
POZEN Announces Appointment of Dennis McNamara to Senior Vice President and Chief Business Officer 7:29 a.m. Jan. 2, 2014 - BusinessWire
Announcements, Studies, and Corporate Updates by Healthcare Companies - Research Report on Horizon Pharma, Novavax, WuXi PharmaTech, Chelsea Therapeutics, and Anika Therapeutics 8:00 a.m. Dec. 24, 2013 - PR Newswire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:05 p.m. Dec. 19, 2013 - Marketwire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼